Drug metabolism in microorganisms
Files in This Item:
|BILE_Drug_Metabolism_in_Microorganisms_Final_Copy.docx||417.23 kB||Microsoft Word||Download|
|Title:||Drug metabolism in microorganisms||Authors:||Murphy, Cormac D.||Permanent link:||http://hdl.handle.net/10197/7674||Date:||Jan-2015||Abstract:||Several wild type and recombinant microorganisms can transform drugs to the equivalent human metabolites. Fungi, such as Cunninghamella spp., and Streptomyces bacteria express cytochrome P450 (CYP) enzymes that enable analogous phase I (oxidative) reactions with a wide range of drugs. The gene encoding the bifunctional CYP102A1 in Bacillus megaterium can be expressed easily in E. coli, and extensive mutagenesis experiments have generated numerous variants that can produce human drug metabolites. Additionally, human CYP isoforms have been expressed in various hosts. The application of microbial CYPs to the production of human drug metabolites is reviewed, and additional applications in the field of drug development are considered.||Type of material:||Journal Article||Publisher:||Springer||Copyright (published version):||2014 Springer Science+Business Media Dordrecht||Keywords:||Bacillus megaterium; Cunninghamella; Cytochrome P450; Metabolism; Streptomyces||DOI:||10.1007/s10529-014-1653-8||Language:||en||Status of Item:||Peer reviewed|
|Appears in Collections:||Biomolecular and Biomedical Science Research Collection|
Show full item record
This item is available under the Attribution-NonCommercial-NoDerivs 3.0 Ireland. No item may be reproduced for commercial purposes. For other possible restrictions on use please refer to the publisher's URL where this is made available, or to notes contained in the item itself. Other terms may apply.